Last updated
Revenue
R&D Expenses
Operating CF
Total Assets
Total Liabilities
Equity
Shares Out.
D/E Ratio
Dilution Watch
Financials
52W LOW $19.5052W HIGH $35.23
Volume
32.67 K
Value Traded
6.97 M
Short % Float
5.84%
Days to Cover
7.0
+6.27%Week
+21.48%1 Month
+27.02%3 Month
+65.19%6 Month
Cash Data
- Monthly Burn
- Burn Trend
- Dilution Risk
- SEC Filing
Key Stats
Market Cap
1.02 B
EPS (TTM)
0.69
P/E Ratio
51.09
Ent. Value
967.49 M
Total Shares
29.21 M
Float Shares
21.88 M
Insiders
28.48%
Institutions
72.58%
Upcoming Catalysts
FDA decisions, readouts and PDUFA dates · scored by probability of approval
| Catalyst | Drug / Treatment | Stage | Prob. of Approval | Description | Drug Type | Therapeutic Area | Source |
|---|---|---|---|---|---|---|---|
PDUFA 2026 | Example Drug Treatment for example condition requiring FDA review | Phase 3 | Small Molecule | Oncology | - |
PoA blends historical approval base rates, trial design score and FDA review track record.
HSTM Catalyst Timeline
Dated clinical, regulatory and corporate events for HealthStream Inc
Catalyst Timeline
Dated clinical, regulatory & corporate events for HealthStream Inc
9Total events
0Upcoming
0Tier-1 (high impact)
2025 to 2026Coverage
Event history 8
▲Quarterly UpdateCorporate
HealthStream reports Q2 2026 results with record revenue of $83.7 million
●Quarterly UpdateCorporate
Company repurchased 432,476 shares for $9.3 million in first half of 2026
Past FDA Catalysts and PDUFA Decisions
How HSTM actually traded into and out of each decision
| Date | Drug | Catalyst | Stage | Reaction | Event Move % | Best Trade % |
|---|---|---|---|---|---|---|
| - | Example Drug | Phase 3 data readout | Phase 3 |
Reaction: 30 trading days around the event · Event Move: close to close on decision day · Best Trade: peak run-up from entry 10 days before the decision
Drug Pipeline Intelligence
No drug pipeline
HealthStream Inc is a services and tools company (CRO, lab tools or healthcare services). The clinical trials it takes part in test other companies' drugs, so it has no drug pipeline of its own to score.
Clinical Trial Results
Readouts, endpoints and source filings for every HSTM program
Inside Trades
| Insider | Side | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| REBROVICK LINDADirector | Sell | -12,000 39,329 held | $35.00 | 10/23/2026 |
Hedge Fund 13F Activity
Hedge Funds invested in HSTM
| Fund | % of Portfolio | Current MV | Shares Owned | Activity |
|---|---|---|---|---|
| No hedge fund reported a 13F position in HSTM for Q2 2026. | ||||
HSTM Institutional Ownership Trends
HSTM Short Interest
Shares sold short, counted twice a month.
5.84%
Short % of Float
of tradable shares sold short
1.3M
Shares Sold Short
-1.3% vs prior count
7.0 High
Days to Cover
trading days of normal volume to buy every short share back
183.2K
Avg Daily Volume
the average used for days to cover
Options Data
Option Volume
Open Interest
Call OI
Put OI
Put-Call Ratio
OI 30-day avg
Today vs avg
Option Volume
Call Vol
Put Vol
Put-Call Ratio
Vol 30-day avg
Today vs avg
Option Chain Statistics
| Expiry | Call Vol | Put Vol | Vol P/C | Call OI | Put OI | OI P/C | IV Call | IV Call OI-Wtd | IV Call Vol-Wtd | IV Put | IV Put OI-Wtd | IV Put Vol-Wtd |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-11-20 | ||||||||||||
Real-Time Option Chain
| Calls | Strike | Puts | ||||
|---|---|---|---|---|---|---|
| Last | Vol | OI | Last | Vol | OI | |
| No data available | ||||||
Calls vs Puts by Expiry
CallsPutsLog scale
Competitive positioning
How HSTM ranks across every disease it competes in
Competitive Position is a premium feature
See how HSTM ranks against every competitor across each disease it develops in: phase, best drug, trials and likelihood of approval.
Start free trialHSTM News
-HSTM
Oct 26, 2026▼ -0.8%today
HealthStream to Host Third Quarter 2026 Earnings Conference Call
HealthStream, Inc. will host a conference call on November 3, 2026, to discuss its third quarter 2026 financial results. The results will be released after market close on November 2, 2026. Participants can join via webcast or telephone, with a replay available for 30 days.
Read more →-HSTM
Sep 15, 2026HealthStream Completes $40 Million Private Placement of Its Common Stock
HealthStream, Inc. has completed a private placement transaction, raising approximately $40 million by issuing 1.5 million shares of its common stock to WJRJJ Ventures, LLC. The shares were sold at a price of $29.50 each. This funding is expected to bolster HealthStream's clinical workforce solutions and overall growth.
Read more →-HSTM
Sep 14, 2026HealthStream Defines a New Enterprise Category Alongside the EHR and ERP, the Enterprise Clinical Workforce Platform (ECWP)
HealthStream has introduced the Enterprise Clinical Workforce Platform (ECWP), a new category aimed at improving clinical workforce solutions in healthcare. This platform is designed to provide a single, verified record for each clinician, complementing existing systems like electronic health records (EHR) and enterprise resource planning (ERP). The initiative aims to streamline healthcare operations and enhance workforce management.
Read more →-HSTM
Aug 11, 2026Humana Healthy Horizons in Indiana Collaborates with HealthStream to Expand and Strengthen Home Care Workforce
Humana Healthy Horizons in Indiana has announced a collaboration with HealthStream to enhance and expand the home care workforce. This partnership is aimed at improving the quality of care provided to patients in Indiana. The initiative reflects a commitment to addressing workforce challenges in the home care sector.
Read more →-HSTM
Aug 3, 2026▲ +5.2%on this news
HealthStream Announces Second Quarter 2026 Results
HealthStream, Inc. reported strong financial results for the second quarter of 2026, achieving record revenues of $83.7 million, which is a 12.5% increase from the same period in 2025. The operating income also saw a substantial rise of 41.4%, reflecting the company's robust growth in the healthcare technology sector.
Read more →-HSTM
Jul 23, 2026HealthStream to Host Second Quarter 2026 Earnings Conference Call
HealthStream, Inc. will host a conference call on August 4, 2026, to discuss its second quarter financial results for 2026. The results will be released after market close on August 3, 2026. This event highlights the company's commitment to transparency and investor relations.
Read more →-HSTM
May 4, 2026HealthStream Announces First Quarter 2026 Results
HealthStream has announced its financial results for the first quarter of 2026. The article provides limited information, primarily focusing on the announcement itself without detailed insights into the financial performance or future outlook.
Read more →-HSTM
Apr 21, 2026HealthStream to Host First Quarter 2026 Earnings Conference Call
HealthStream, Inc. will host a conference call on May 5, 2026, to discuss its first quarter financial results for 2026. The results will be released after market close on May 4, 2026. Participants can join via webcast or telephone, with a replay available for 30 days. The announcement highlights HealthStream's commitment to transparency with investors.
Read more →-HSTM
Mar 26, 2026Virsys12® Named a Leader in the IDC MarketScape: U.S. Provider Data Management for Payers 2025–2026 Vendor Assessment
HealthStream's Virsys12 has been named a Leader in the IDC MarketScape for U.S. Provider Data Management for Payers 2025-2026. The assessment evaluated twelve vendors, highlighting Virsys12's strengths in provider data management, including real-time visibility and configurable workflows. This recognition follows HealthStream's acquisition of Virsys12 in October 2025.
Read more →-HSTM
Mar 13, 2026HealthStream Announces Share Repurchase Program
HealthStream's Board of Directors has approved a share repurchase program allowing the company to buy back up to $10 million of its common stock. The program will operate under specific conditions and will end by September 12, 2026, or when the budget is exhausted. The company retains the right to modify or suspend the program at any time.
Read more →-HSTM
Feb 23, 2026HealthStream Announces Fourth Quarter & Full-Year 2025 Results
HealthStream reported a record revenue of $79.7 million for Q4 2025, a 7.4% increase from Q4 2024. However, operating income and net income saw significant declines due to a $3.8 million charge from a CEO stock gift. The company also completed two acquisitions and announced a dividend increase of 12.9%. Overall, adjusted EBITDA rose by 16.4% year-over-year.
Read more →-HSTM
Jul 26, 2021HEALTHSTREAM ANNOUNCES SECOND QUARTER 2021 RESULTS
Contact: Scott A. Roberts Chief Financial Officer (615) 301-3182 ir@healthstream.com Media: Mollie Condra, Ph.D. Vice President, Investor Relations & Communications (615) 301-3237 mollie.condra@healthstream.com HEALTHSTREAM ANNOUNCES SECOND QUARTER 2021 RESU
Read more →-HSTM
Apr 26, 2021HEALTHSTREAM ANNOUNCES FIRST QUARTER 2021 RESULTS
Contact: Scott A. Roberts Chief Financial Officer (615) 301-3182 ir@healthstream.com Media: Mollie Condra, Ph.D. Vice President, Investor Relations & Communications (615) 301-3237 mollie.condra@healthstream.com HEALTHSTREAM ANNOUNCES FIRST QUARTER 2021 RESUL
Read more →-HSTM
Feb 22, 2021HEALTHSTREAM ANNOUNCES FOURTH QUARTER & FULL-YEAR 2020 RESULTS
Contact: Scott A. Roberts Chief Financial Officer (615) 301-3182 ir@healthstream.com Media: Mollie Condra, Ph.D. Vice President, Investor Relations & Communications (615) 301-3237 mollie.condra@healthstream.com HEALTHSTREAM ANNOUNCES FOURTH QUARTER & FULL-YE
Read more →-HSTM
Jan 19, 2021: Contact: Mollie Condra, Ph.D. HealthStream (615)-301-3237 mollie.condra@healthstream.com HealthStream Acquires ComplyALIGN Nashville, Tennessee (
For Immediate Release:Contact: Mollie Condra, Ph.D. mollie.condra@healthstream.com HealthStream Acquires ComplyALIGN Nashville, Tennessee (January 19, 2021) - HealthStream (Nasdaq: HSTM), a leading provider of workforce and provider solutions for the healthcare industry, toda
Read more →-HSTM
Dec 10, 2020: Contact: Mollie Condra, Ph.D. HealthStream (615)-301-3237 mollie.condra@healthstream.com HealthStream Acquires myClinicalExchange For the first time, HealthStream's footprint expands
For Immediate Release:Contact: Mollie Condra, Ph.D. mollie.condra@healthstream.com HealthStream Acquires myClinicalExchange For the first time, HealthStream's footprint expands to include the healthcare workforce before graduation, providing new opportunities to make the tran
Read more →-HSTM
Dec 3, 2020HealthStream Closes Acquisition of ANSOS Staff Scheduling
P R E S S R E L E A S E For Immediate Release: Contact: Mollie Condra, Ph.D. mollie.condra@healthstream.com HealthStream Closes Acquisition of ANSOS Staff Scheduling Nashville, Tennessee (December 3, 2020) - HealthStream (Nasdaq: HSTM), a leading provider of workforce and pr
Read more →-HSTM
Nov 30, 2020HealthStream to Acquire ANSOS Staff Scheduling from Change Healthcare
P R E S S R E L E A S E For Immediate Release: Contact: Mollie Condra, Ph.D. mollie.condra@healthstream.com HealthStream to Acquire ANSOS Staff Scheduling from Change Healthcare Establishes HealthStream as a market leader in healthcare workforce scheduling business; Acquisi
Read more →-HSTM
Oct 26, 2020HEALTHSTREAM ANNOUNCES THIRD QUARTER 2020 RESULTS
Contact: Scott A. Roberts Chief Financial Officer (615) 301-3182 ir@healthstream.com Media: Mollie Condra, Ph.D. Vice President, Investor Relations & Communications (615) 301-3237 mollie.condra@healthstream.com HEALTHSTREAM ANNOUNCES THIRD QUARTER 2020 RESUL
Read more →-HSTM
Oct 12, 2020HealthStream Acquires ShiftWizard, Expanding its Nurse & Staff Scheduling Solutions for Healthcare Providers
For Immediate Release:Contact: Mollie Condra, Ph.D. mollie.condra@healthstream.com HealthStream Acquires ShiftWizard, Expanding its Nurse & Staff Scheduling Solutions for Healthcare Providers Named Category Leader in "2020 Best in KLAS Software & Services" report, ShiftWizard
Read more →About HealthStream Inc
Headquarters500 11TH AVENUE NORTH, NASHVILLE, TN
BIOPHARMAWATCH ELITE PLUS
Trade the next HSTM catalyst before the market reprices
Every FDA decision, PoA score, 13F move and dilution flag on this page, for 1,100+ biotech tickers. From $19/mo billed annually.
Cancel anytime